A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma

NCT03890666 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

333

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Albuterol eMDPI DS
DRUG: albuterol

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.